| Ident. | Authors (with country if any) | Title |
|---|
| 000037 (2021) |
Isabel Fambuena-Muedra [Espagne] ; Marta Jiménez-García [Belgique] ; Sarah Hershko [Belgique] ; Irene Altemir-G Mez [Espagne] ; Ana Tobarra-L Pez [Espagne] | What can visual caregivers expect with patients treated for SARS-CoV-2? An analysis of ongoing clinical trials and ocular side effects. |
| 000057 (2021) |
Nobuaki Mori [Japon] ; Mitsuya Katayama [Japon] ; Shigenari Nukaga [Japon] | Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia. |
| 000130 (2021) |
Yudibeth Sixto-L Pez [Mexique] ; José Correa-Basurto [Mexique] ; Martiniano Bello [Mexique] ; Bruno Landeros-Rivera [France] ; Jose Antonio Garz N-Tiznado [Mexique] ; Sarita Monta O [Mexique] | Structural insights into SARS-CoV-2 spike protein and its natural mutants found in Mexican population. |
| 000233 (2021) |
Olfa Noureddine [Tunisie] ; Noureddine Issaoui [Tunisie] ; Mouna Medimagh [Tunisie] ; Omar Al-Dossary [Arabie saoudite] ; Houda Marouani [Tunisie] | Quantum chemical studies on molecular structure, AIM, ELF, RDG and antiviral activities of hybrid hydroxychloroquine in the treatment of COVID-19: Molecular docking and DFT calculations. |
| 000292 (2021) |
Hesham Refaat [Égypte] ; Fatma M. Mady [Égypte] ; Hatem A. Sarhan [Égypte] ; Heba S. Rateb [Égypte] ; Eman Alaaeldin [Égypte] | Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. |
| 000294 (2021) |
Sanjay Kumar Mishra [Inde] ; Timir Tripathi [Inde] | One year update on the COVID-19 pandemic: Where are we now? |
| 000315 (2021) |
Cristina Ciuca [Italie] ; Marianna Fabi [Italie] ; Daniela Di Luca [Italie] ; Fabio Niro [Italie] ; Chiara Ghizzi [Italie] ; Andrea Donti [Italie] ; Anna Balducci [Italie] ; Alessandro Rocca [Italie] ; Chiara Zarbo [Italie] ; Gaetano Domenico Gargiulo [Italie] ; Marcello Lanari [Italie] | Myocarditis and coronary aneurysms in a child with acute respiratory syndrome coronavirus 2. |
| 000396 (2021) |
Agata Blasiak ; Jhin Jieh Lim ; Shirley Gek Kheng Seah ; Theodore Kee ; Alexandria Remus ; De Hoe Chye ; Pui San Wong ; Lissa Hooi ; Anh T L. Truong ; Nguyen Le ; Conrad E Z. Chan ; Rishi Desai ; Xianting Ding ; Brendon J. Hanson ; Edward Kai-Hua Chow ; Dean Ho | IDentif.AI: Rapidly optimizing combination therapy design against severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) with digital drug development. |
| 000428 (2021) |
A A Kamalov [Russie] ; V Yu Mareev [Russie] ; Ya A. Orlova [Russie] ; A G Plisyk [Russie] ; Z A Akopyan [Russie] ; Yu V. Mareev [Royaume-Uni] ; E A Mershina [Russie] ; Yu L. Begrambekova [Russie] ; P V Pakhomov [Russie] | Hydroxychloroquine in patients with novel coronavirus infection (COVID-19): a case-control study. |
| 000439 (2021) |
Harmanjit Singh [Inde] ; Prerna Chauhan [Inde] ; Ashish Kumar Kakkar [Inde] | Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead. |
| 000452 (2021) |
Abdulrhman Mohana [Arabie saoudite] ; Tarek Sulaiman [Arabie saoudite] ; Nagla Mahmoud [Arabie saoudite] ; Mustafa Hassanein [Arabie saoudite] ; Amel Alfaifi [Arabie saoudite] ; Eissa Alenazi [Arabie saoudite] ; Nashwa Radwan [Arabie saoudite] ; Nasser Alkhalifah [Arabie saoudite] ; Ehab Elkady [Arabie saoudite] ; Abdullah Almohaizeie [Arabie saoudite] ; Fouad Abogazalah [Arabie saoudite] ; Khaled Alabdulkareem [Arabie saoudite] ; Fahad Alghofaili [Arabie saoudite] ; Hani Jokdar [Arabie saoudite] ; Fahad Alrabiah [Arabie saoudite] | Hydroxychloroquine Safety Outcome within Approved Therapeutic Protocol for COVID-19 Outpatients in Saudi Arabia. |
| 000472 (2021) |
Sameer Al-Abdi [Arabie saoudite] ; Maryam Al-Aamri [Arabie saoudite] | G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost. |
| 000547 (2021) |
Steven M. Smoke [États-Unis] ; Karan Raja [États-Unis] ; Patrick Hilden [États-Unis] ; Nicole M. Daniel [États-Unis] | Early clinical outcomes with tocilizumab for severe COVID-19: a two-centre retrospective study. |
| 000548 (2021) |
Andrea Giacomelli [Italie] ; Gabriele Pagani [Italie] ; Anna L. Ridolfo [Italie] ; Letizia Oreni [Italie] ; Federico Conti [Italie] ; Laura Pezzati [Italie] ; Lucia Bradanini [Italie] ; Giacomo Casalini [Italie] ; Cinzia Bassoli [Italie] ; Valentina Morena [Italie] ; Simone Passerini [Italie] ; Giuliano Rizzardini [Italie, Afrique du Sud] ; Chiara Cogliati [Italie] ; Elisa Ceriani [Italie] ; Riccardo Colombo [Italie] ; Stefano Rusconi [Italie] ; Cristina Gervasoni [Italie] ; Dario Cattaneo [Italie] ; Spinello Antinori [Italie] ; Massimo Galli [Italie] | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: A retrospective cohort study. |
| 000571 (2021) |
Mukesh Kumar [Inde] ; Jitender Madan [Inde] ; Rupinder Kaur Sodhi [Inde] ; Shashi Bala Singh [Inde] ; Anju Katyal [Inde] | Decoding the silent walk of COVID-19: Halting its spread using old bullets. |
| 000610 (2021) |
Majid Mokhtari [Iran] ; Minoo Mohraz [Iran] ; Mohammad Mehdi Gouya [Iran] ; Hengameh Namdari Tabar [Iran] ; Jafar-Sadegh Tabrizi [Iran] ; Katayoun Tayeri [Iran] ; Saeide Aghamohamadi [Iran] ; Zahra Rajabpoor [Iran] ; Manoochehr Karami [Iran] ; Alireza Raeisi [Iran] ; Hamid Rahmani [Iran] ; Hossein Khalili [Iran] | Clinical outcomes of patients with mild COVID-19 following treatment with hydroxychloroquine in an outpatient setting. |
| 000635 (2021) |
Edward J. Calabrese [États-Unis] ; Jaap C. Hanekamp [Pays-Bas] ; Yannic N. Hanekamp [Pays-Bas] ; Rachna Kapoor [États-Unis] ; Gaurav Dhawan [États-Unis] ; Evgenios Agathokleous [République populaire de Chine] | Chloroquine commonly induces hormetic dose responses. |
| 000761 (2021) |
S Udhaya Kumar [Inde] ; N Madhana Priya [Inde] ; S R Nithya [Inde] ; Priyanka Kannan [Inde] ; Nikita Jain [Inde] ; D Thirumal Kumar [Inde] ; R. Magesh [Inde] ; Salma Younes [Qatar] ; Hatem Zayed [Qatar] ; C George Priya Doss [Inde] | A review of novel coronavirus disease (COVID-19): based on genomic structure, phylogeny, current shreds of evidence, candidate vaccines, and drug repurposing. |
| 000784 (2021) |
Francis Atemnkeng [États-Unis] ; Harith Alataby [États-Unis] ; Jack Demirjian [États-Unis] ; Foma Munoh Kenne [États-Unis] ; Jay Nfonoyim [États-Unis] | A Novel Report on the Compassionate Use of Baricitinib in Treating a Pediatric Patient With Severe Symptoms of COVID-19 Infection. |
| 000841 (2020) |
Narayan Prasad [Inde] ; N. Gopalakrishnan [Inde] ; Manisha Sahay [Inde] ; Amit Gupta [Inde] ; Sanjay K. Agarwal [Inde] | Epidemiology, Genomic Structure, the Molecular Mechanism of Injury, Diagnosis and Clinical Manifestations of Coronavirus Infection: An Overview. |
| 000922 (2020) |
Cristina Silvestri [Italie] ; Silvio Di Stante [Italie] ; Veronica Bertuzzi [Italie] ; Mauro Martello [Italie] ; Marco Palladino [Italie] ; Xhensila Grabocka [Italie] ; Hrissanthi Kulurianu [Italie] ; Flavia Manenti [Italie] ; Francesca Pizzolante [Italie] ; Assunta Cardillo [Italie] ; Angelo Francioso [Italie] ; Osmy Paci Della Costanza [Italie] ; Chiara Valentini [Italie] ; Marina Di Luca [Italie] | [SARS CoV-2 related disease features in a population of chronic hemodialysis patients]. |
